Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 46 EP applications Christiane Marti has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12700094

INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)

IPC classification:
A61P 27/02, A61K 31/416, A61K 31/407, A61K 31/403, C07D 471/04, C07D 417/14, C07D 417/12, C07D 409/14, C07D 405/14, C07D 403/14, C07D 403/12, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP12723241

SUSPENSION TYPE TOPICAL FORMULATIONS COMPRISING CYCLIC DEPSIPEPTIDE

IPC classification:
A61K 47/14, A61K 47/06, A61K 38/15, A61K 9/06, A61K 9/00, A61P 17/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP12727933

PROCESSES FOR THE MANUFACTURE OF MACROCYCLIC DEPSIPEPTIDES AND NEW INTERMEDIATES

IPC classification:
C07K 11/02
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12766749

COMPOUNDS AND COMPOSITIONS AS PDGFR KINASE INHIBITORS

IPC classification:
A61K 31/437, C07D 471/04, A61P 37/00
Applicant:
Novartis Pharmaceuticals UK Limited
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12762445

COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

IPC classification:
A61K 31/437, C07D 471/04, A61P 11/06
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756884

COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

IPC classification:
A61K 31/437, C07D 471/04, A61P 29/00, A61P 17/00, A61P 11/00, A61P 3/00
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12791859

QUINAZOLINE DERIVATIVES AS PI3K MODULATORS

IPC classification:
A61K 31/517, C07D 487/08, C07D 413/14, C07D 403/14, C07D 403/04, C07D 401/14, C07D 401/04, C07D 239/74, A61P 37/00, A61P 35/00, A61P 29/00, A61P 11/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12738616

SOLID FORMS AND SALTS OF TETRAHYDRO-PYRIDO-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/517, C07D 471/04, A61P 29/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION WITHDRAWN
EP12818825

USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K

IPC classification:
A61K 31/519, A61K 31/517, A61P 33/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP12823037

QUINOLINE DERIVATIVES

IPC classification:
A61K 31/498, C07D 413/12, C07D 401/14, C07D 401/12, A61P 35/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12823036

DIHYDRO-BENZO-OXAZINE AND DIHYDRO-PYRIDO-OXAZINE DERIVATIVES

IPC classification:
A61K 31/5365, A61K 31/536, C07D 498/04, C07D 413/14, A61P 37/08, A61P 35/00, A61P 33/06, A61P 19/02
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP12743023

TETRAHYDROPYRIDO-PYRIDINE AND TETRAHYDROPYRIDO-PYRIMIDINE COMPOUNDS AND USE THEREOF AS C5A RECEPTOR MODULATORS

IPC classification:
A61K 31/519, A61K 31/4375, C07D 471/04, A61P 37/00, A61P 27/02
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
PATENT GRANTED
EP13729096

COMPLEMENT PATHWAY MODULATORS AND USES THEREOF

IPC classification:
C07D 417/06, C07D 413/06, C07D 403/06, A61P 37/00, A61P 27/02
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
PATENT GRANTED
EP13729573

COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR ACTIVITY

IPC classification:
A61K 31/395, C07D 401/12, C07D 235/30
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13733200

COMPLEMENT PATHWAY MODULATORS AND USES THEREOF

IPC classification:
A61K 31/517, C07D 413/14, C07D 409/12, C07D 405/12, C07D 403/14, C07D 403/12, C07D 403/04, C07D 401/14, C07D 401/12, C07D 239/95, A61P 37/00, A61P 27/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13765775

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/497, A61K 31/4745, A61K 31/444, A61K 31/4439, C07D 471/04, C07D 417/14, C07D 403/14, C07D 401/14, A61P 37/00, A61P 27/00, A61P 19/00, A61P 11/00, A61P 9/00, A61P 3/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13762560

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/506, A61K 31/4162, A61K 31/416, C07F 7/08, C07D 471/04, C07D 403/14, C07D 403/06, A61P 37/00, A61P 27/00, A61P 19/00, A61P 11/00, A61P 9/00, A61P 3/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP13762561

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/506, A61K 31/427, A61K 31/4162, A61K 31/416, C07D 417/14, C07D 417/04, C07D 403/14, C07D 403/06, A61P 37/00, A61P 27/00, A61P 19/00, A61P 11/00, A61P 9/00, A61P 3/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP13762559

PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS

IPC classification:
A61K 31/416, A61K 31/404, C07D 403/12, C07D 403/06, A61P 37/00, A61P 27/00, A61P 19/00, A61P 11/00, A61P 9/00, A61P 3/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP13752768

1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

IPC classification:
A61K 31/501, C07D 487/10, C07D 487/04, C07D 471/14, C07D 471/08, C07D 471/04, C07D 417/14, C07D 413/14, C07D 409/14, C07D 405/14, C07D 403/14, C07D 401/14, C07D 401/12, A61P 21/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13785621

2'-ETHYNYL NUCLEOSIDE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS

IPC classification:
C07H 19/067, A61P 31/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13795867

OXAZOLIDIN-2-ONE-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/506, C07D 417/14, C07D 413/14, A61P 35/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP13824177

SOLID FORM OF DIHYDRO-PYRIDO-OXAZINE DERIVATIVE

IPC classification:
A61K 31/5365, C07D 498/04, A61P 29/00
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP14719470

2-(1H-INDOL-4-YLMETHYL)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBONITRILE DERIVATIVES AS COMPLEMENT FACTOR B INHIBITORS USEFUL FOR THE TREATMENT OF OPHTHALMIC DISEASES

IPC classification:
A61P 27/02, A61K 31/437, C07D 471/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
PATENT GRANTED
EP14728655

PYRIMIDIN-4-YL)OXY)-1H-INDOLE-1-CARBOXAMIDE DERIVATIVES AND USE THEREOF

IPC classification:
A61K 31/506, C07D 403/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14744744

PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS

IPC classification:
A61P 37/00, A61P 27/00, A61K 31/5377, A61K 31/4545, A61K 31/454, C07D 417/14, C07D 403/06, C07D 401/06, C07D 413/14, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP14747273

AMINOMETHYL-BIARYL DERIVATIVES AS COMPLEMENT FACTOR D INHIBITORS AND USES THEREOF

IPC classification:
C07C 229/06, C07C 233/75, C07C 311/21, C07D 213/81
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14803001

COMPOSITIONS AND METHODS FOR MODULATING FARNESOID X RECEPTORS

IPC classification:
C07D 491/052, C07D 471/04, A61K 31/4162
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP14802972

2-BENZYL-BENZIMIDAZOLE COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF

IPC classification:
A61P 27/02, C07D 235/14, A61K 31/4184, C07D 235/12
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15714147

MONOBACTAM ORGANIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

IPC classification:
A61K 31/437, A61K 31/454, A61K 31/4439, A61K 31/496, A61K 31/427, A61P 31/04, C07D 487/04, C07D 417/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14726416

PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

IPC classification:
A61P 37/00, A61P 35/00, A61P 17/00, A61K 31/497, C07D 417/04, C07D 409/04, C07D 403/14, C07D 403/04, C07D 401/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
The patent has been granted
EP14726415

AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

IPC classification:
C07D 417/14, C07D 417/04, C07D 413/04, C07D 409/04, C07D 403/14, C07D 403/04, C07D 401/04, C07D 405/14, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15721435

ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LPXC INHIBITORS

IPC classification:
A61P 31/04, A61K 31/42, C07D 261/04, C07D 413/10, C07D 413/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14726414

AMINO PYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

IPC classification:
A61P 11/06, A61K 31/4439, C07D 491/107, C07D 417/04, C07D 413/04, C07D 401/04, C07D 213/73, C07D 413/14, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15724409

COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS

IPC classification:
A61P 17/00, A61P 35/00, A61P 37/00, A61P 31/12, A61P 29/00, A61K 31/519, C07D 487/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15727098

COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS

IPC classification:
A61P 35/00, A61P 37/00, A61P 31/12, A61P 29/00, A61K 31/519, C07D 487/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15727792

METHODS FOR MAKING CONJUGATES FROM DISULFIDE-CONTAINING PROTEINS

IPC classification:
A61K 47/50
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15732439

AURISTATIN DERIVATIVES AND CONJUGATES THEREOF

IPC classification:
A61K 47/50, C07K 5/02
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15742104

THIOPHEN-2-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61P 27/06, A61K 31/4545, C07D 409/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15742105

CYCLOHEXEN-1-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61P 27/06, C07D 401/12, A61K 31/445, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15742103

INDANE AND INDOLINE DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61P 27/06, A61K 31/445, C07D 401/12, C07D 401/10, C07D 401/14
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15750132

QUINOLONE DERIVATIVES AS ANTIBACTERIALS

IPC classification:
A61P 31/04, A61K 31/4704, C07D 215/38, C07D 215/22
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP17157570

OXAZOLIDIN-2-ONE-PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF SKIN FIBROSIS, SCLERODERMA, HYPERTROPHIC SCARS OR KELOIDS

IPC classification:
A61P 17/00, A61K 31/506
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
Request for examination was made
EP15798567

AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE

IPC classification:
A61P 35/00, A61K 38/12, C07K 7/64
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
Request for examination was made
EP15816893

ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LPXC INHIBITORS

IPC classification:
C07D 261/08, C07D 413/12, A61K 31/42, C07D 413/06
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
Request for examination was made
EP16720183

FUSED TRICYCLIC PYRAZOLE DERIVATIVES USEFUL FOR MODULATING FARNESOID X RECEPTORS

IPC classification:
A61P 1/16, A61K 31/4162, C07D 493/04
Applicant:
Novartis AG
Agent:
Christiane Marti, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature